TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 310 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2020. The put-call ratio across all filers is 1.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $0 | – | 2 | 0.0% | 0.00% | – |
Q1 2024 | $0 | – | 2 | 0.0% | 0.00% | – |
Q4 2023 | $0 | -100.0% | 2 | -99.9% | 0.00% | – |
Q3 2023 | $24 | -97.1% | 1,580 | -97.0% | 0.00% | -100.0% |
Q2 2023 | $814 | -97.1% | 51,836 | -96.9% | 0.00% | -92.3% |
Q1 2023 | $27,856 | +5.8% | 1,690,341 | +0.2% | 0.01% | +8.3% |
Q4 2022 | $26,320 | -99.9% | 1,687,141 | -0.2% | 0.01% | -50.0% |
Q3 2022 | $21,919,000 | -7.5% | 1,690,041 | +0.2% | 0.02% | +71.4% |
Q2 2022 | $23,685,000 | -2.0% | 1,686,972 | 0.0% | 0.01% | -26.3% |
Q1 2022 | $24,158,000 | -38.5% | 1,686,972 | -41.5% | 0.02% | +171.4% |
Q4 2021 | $39,276,000 | +61.8% | 2,881,546 | +94.5% | 0.01% | -36.4% |
Q3 2021 | $24,273,000 | +37.6% | 1,481,860 | +41.4% | 0.01% | +37.5% |
Q2 2021 | $17,637,000 | +9.4% | 1,047,930 | +18.7% | 0.01% | 0.0% |
Q1 2021 | $16,118,000 | +32.2% | 882,748 | +31.8% | 0.01% | +33.3% |
Q4 2020 | $12,192,000 | -16.6% | 669,873 | -18.3% | 0.01% | -25.0% |
Q3 2020 | $14,619,000 | -0.7% | 819,500 | -0.2% | 0.01% | -27.3% |
Q2 2020 | $14,728,000 | +9.3% | 821,345 | -7.4% | 0.01% | +10.0% |
Q1 2020 | $13,470,000 | -31.6% | 887,409 | -11.0% | 0.01% | 0.0% |
Q4 2019 | $19,680,000 | +14.4% | 997,424 | -0.3% | 0.01% | -9.1% |
Q3 2019 | $17,204,000 | +10.8% | 1,000,224 | +14.0% | 0.01% | +22.2% |
Q2 2019 | $15,530,000 | +9.0% | 877,355 | +25.5% | 0.01% | -10.0% |
Q1 2019 | $14,244,000 | +3834.8% | 699,192 | +3151.9% | 0.01% | – |
Q4 2018 | $362,000 | – | 21,501 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Adelphi Capital LLP | 9,270,535 | $188,841,000 | 39.13% |
Sachem Head Capital | 5,963,600 | $121,479,000 | 7.38% |
NINE MASTS CAPITAL Ltd | 1,049,886 | $21,415,000 | 6.68% |
Paulson & Co. | 26,489,422 | $539,590,000 | 5.77% |
Blackcrane Capital, LLC | 189,549 | $3,861,000 | 5.16% |
Glenview Capital Management | 26,112,660 | $531,915,000 | 4.75% |
Exane Asset Management | 430,369 | $8,766,617,000 | 4.26% |
Velanne Asset Management Ltd | 281,972 | $5,744,000 | 3.97% |
Bluefin Trading, LLC | 1,204,702 | $24,540,000 | 3.55% |
Endurant Capital Management LP | 437,436 | $8,911,000 | 3.52% |